Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypoxia-Ischemia, Brain | 14 | 2023 | 56 | 2.920 |
Why?
|
| Cerebral Cortex | 8 | 2018 | 415 | 2.000 |
Why?
|
| Premature Birth | 8 | 2021 | 150 | 1.830 |
Why?
|
| Sheep | 25 | 2023 | 128 | 1.810 |
Why?
|
| Brain Injuries | 8 | 2022 | 268 | 1.790 |
Why?
|
| Fetus | 16 | 2020 | 157 | 1.410 |
Why?
|
| Hypothermia, Induced | 5 | 2023 | 93 | 1.400 |
Why?
|
| Inflammation | 9 | 2021 | 1030 | 1.350 |
Why?
|
| Hypoxia | 6 | 2020 | 169 | 1.220 |
Why?
|
| White Matter | 7 | 2021 | 174 | 1.120 |
Why?
|
| Oligodendroglia | 10 | 2021 | 107 | 1.060 |
Why?
|
| Brain | 15 | 2021 | 2176 | 1.020 |
Why?
|
| Cerebral Infarction | 2 | 2023 | 103 | 1.010 |
Why?
|
| Interneurons | 3 | 2023 | 70 | 1.000 |
Why?
|
| Animals | 47 | 2023 | 20881 | 0.830 |
Why?
|
| Lipopolysaccharides | 6 | 2021 | 455 | 0.820 |
Why?
|
| Fetal Diseases | 3 | 2020 | 64 | 0.810 |
Why?
|
| Infant, Premature | 6 | 2021 | 284 | 0.780 |
Why?
|
| Neocortex | 1 | 2020 | 17 | 0.740 |
Why?
|
| Pregnancy | 19 | 2021 | 2334 | 0.740 |
Why?
|
| Nerve Fibers, Myelinated | 5 | 2015 | 49 | 0.710 |
Why?
|
| Brain Ischemia | 6 | 2020 | 665 | 0.700 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2021 | 234 | 0.700 |
Why?
|
| Connexin 43 | 1 | 2020 | 62 | 0.700 |
Why?
|
| Disease Models, Animal | 11 | 2020 | 2550 | 0.670 |
Why?
|
| Reperfusion Injury | 1 | 2022 | 320 | 0.670 |
Why?
|
| Neurons | 4 | 2018 | 881 | 0.640 |
Why?
|
| GABAergic Neurons | 1 | 2018 | 17 | 0.640 |
Why?
|
| Infant, Premature, Diseases | 2 | 2017 | 85 | 0.590 |
Why?
|
| Peptides | 1 | 2020 | 455 | 0.590 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 454 | 0.580 |
Why?
|
| Hyaluronic Acid | 3 | 2017 | 206 | 0.570 |
Why?
|
| Nerve Net | 1 | 2018 | 181 | 0.560 |
Why?
|
| Developmental Disabilities | 2 | 2014 | 119 | 0.540 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2020 | 2223 | 0.520 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2017 | 154 | 0.490 |
Why?
|
| Fetal Hypoxia | 4 | 2014 | 5 | 0.480 |
Why?
|
| Brain Diseases | 1 | 2015 | 78 | 0.470 |
Why?
|
| Seizures | 3 | 2021 | 279 | 0.470 |
Why?
|
| Infant, Newborn | 10 | 2021 | 2455 | 0.470 |
Why?
|
| Child Development | 2 | 2013 | 102 | 0.460 |
Why?
|
| Dendrites | 2 | 2014 | 44 | 0.450 |
Why?
|
| Asphyxia | 3 | 2012 | 8 | 0.440 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2005 | 266 | 0.440 |
Why?
|
| Parvalbumins | 2 | 2023 | 29 | 0.390 |
Why?
|
| Cell Lineage | 2 | 2011 | 146 | 0.390 |
Why?
|
| Neoplasms | 1 | 2022 | 1667 | 0.370 |
Why?
|
| Aminoquinolines | 2 | 2021 | 14 | 0.370 |
Why?
|
| Toll-Like Receptor 7 | 2 | 2021 | 17 | 0.370 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 239 | 0.360 |
Why?
|
| Gliosis | 2 | 2020 | 51 | 0.360 |
Why?
|
| Encephalitis | 2 | 2021 | 43 | 0.350 |
Why?
|
| Imidazoles | 2 | 2021 | 175 | 0.350 |
Why?
|
| Cognition | 1 | 2013 | 513 | 0.340 |
Why?
|
| Gestational Age | 8 | 2020 | 389 | 0.330 |
Why?
|
| Asphyxia Neonatorum | 3 | 2020 | 14 | 0.330 |
Why?
|
| Dizocilpine Maleate | 2 | 2005 | 43 | 0.330 |
Why?
|
| Oligodendrocyte Precursor Cells | 2 | 2019 | 2 | 0.330 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2014 | 328 | 0.330 |
Why?
|
| Clonidine | 1 | 2008 | 66 | 0.310 |
Why?
|
| Neuroprotective Agents | 3 | 2020 | 317 | 0.310 |
Why?
|
| Umbilical Cord | 5 | 2008 | 19 | 0.310 |
Why?
|
| Neurogenesis | 3 | 2019 | 32 | 0.310 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2008 | 57 | 0.310 |
Why?
|
| Rats | 5 | 2020 | 5300 | 0.300 |
Why?
|
| Extracellular Matrix | 3 | 2020 | 493 | 0.290 |
Why?
|
| Animals, Newborn | 7 | 2020 | 396 | 0.290 |
Why?
|
| Electroencephalography | 6 | 2021 | 418 | 0.290 |
Why?
|
| Demyelinating Diseases | 2 | 2019 | 57 | 0.270 |
Why?
|
| Female | 24 | 2021 | 38074 | 0.270 |
Why?
|
| Humans | 23 | 2022 | 68618 | 0.260 |
Why?
|
| Receptors, AMPA | 1 | 2005 | 99 | 0.250 |
Why?
|
| Time Factors | 9 | 2020 | 4655 | 0.250 |
Why?
|
| Stem Cells | 4 | 2020 | 248 | 0.240 |
Why?
|
| Models, Biological | 3 | 2021 | 981 | 0.240 |
Why?
|
| Neural Stem Cells | 3 | 2013 | 32 | 0.240 |
Why?
|
| Gene Expression | 1 | 2005 | 770 | 0.210 |
Why?
|
| Myelin Sheath | 4 | 2019 | 115 | 0.210 |
Why?
|
| Hippocampus | 2 | 2018 | 471 | 0.200 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 17 | 0.200 |
Why?
|
| Ischemia | 1 | 2023 | 229 | 0.190 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 13 | 0.190 |
Why?
|
| Infusions, Intraventricular | 1 | 2020 | 8 | 0.190 |
Why?
|
| Biomimetics | 1 | 2020 | 17 | 0.180 |
Why?
|
| Connexins | 1 | 2020 | 35 | 0.180 |
Why?
|
| Neuronal Plasticity | 2 | 2013 | 274 | 0.180 |
Why?
|
| Immunomodulation | 1 | 2020 | 35 | 0.180 |
Why?
|
| Microglia | 5 | 2019 | 143 | 0.180 |
Why?
|
| Tachycardia | 1 | 2020 | 53 | 0.170 |
Why?
|
| Remyelination | 1 | 2019 | 1 | 0.170 |
Why?
|
| Pyramidal Cells | 2 | 2013 | 79 | 0.170 |
Why?
|
| Models, Theoretical | 1 | 2022 | 384 | 0.170 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 201 | 0.160 |
Why?
|
| Heart Rate, Fetal | 3 | 2007 | 12 | 0.160 |
Why?
|
| Liposomes | 1 | 2019 | 107 | 0.160 |
Why?
|
| Lateral Ventricles | 1 | 2018 | 2 | 0.160 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2018 | 10 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 244 | 0.160 |
Why?
|
| Ependymoglial Cells | 1 | 2018 | 7 | 0.160 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2018 | 30 | 0.160 |
Why?
|
| Perinatal Care | 1 | 2018 | 17 | 0.160 |
Why?
|
| Fetal Blood | 1 | 2018 | 131 | 0.160 |
Why?
|
| Axons | 1 | 2019 | 139 | 0.150 |
Why?
|
| Oxidative Stress | 1 | 2022 | 718 | 0.150 |
Why?
|
| Toll-Like Receptors | 1 | 2018 | 56 | 0.150 |
Why?
|
| Substantia Nigra | 1 | 2018 | 102 | 0.150 |
Why?
|
| Immune Tolerance | 1 | 2018 | 114 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2019 | 2673 | 0.150 |
Why?
|
| Glutathione | 1 | 2019 | 343 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 626 | 0.150 |
Why?
|
| Hypothermia | 2 | 2019 | 37 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 50 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2020 | 310 | 0.140 |
Why?
|
| Hyaluronoglucosaminidase | 2 | 2014 | 43 | 0.140 |
Why?
|
| Cytokines | 1 | 2021 | 866 | 0.140 |
Why?
|
| Glucose | 1 | 2018 | 307 | 0.140 |
Why?
|
| Mass Screening | 1 | 2022 | 843 | 0.130 |
Why?
|
| Astrocytes | 1 | 2018 | 270 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 331 | 0.130 |
Why?
|
| Species Specificity | 2 | 2018 | 303 | 0.130 |
Why?
|
| Cell Adhesion Molecules | 2 | 2014 | 199 | 0.130 |
Why?
|
| Rats, Wistar | 2 | 2018 | 371 | 0.130 |
Why?
|
| Age Factors | 2 | 2013 | 1864 | 0.130 |
Why?
|
| Blood Pressure | 4 | 2021 | 1451 | 0.120 |
Why?
|
| Brain Damage, Chronic | 2 | 2011 | 25 | 0.120 |
Why?
|
| Caspase 3 | 5 | 2014 | 233 | 0.120 |
Why?
|
| Hypnotics and Sedatives | 1 | 2014 | 96 | 0.120 |
Why?
|
| Caudate Nucleus | 1 | 2014 | 56 | 0.120 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 346 | 0.110 |
Why?
|
| Analgesics | 1 | 2014 | 118 | 0.110 |
Why?
|
| Anticonvulsants | 1 | 2014 | 223 | 0.110 |
Why?
|
| Nerve Regeneration | 1 | 2013 | 42 | 0.110 |
Why?
|
| Anisotropy | 1 | 2013 | 105 | 0.110 |
Why?
|
| Dendritic Spines | 1 | 2013 | 76 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2020 | 2689 | 0.100 |
Why?
|
| Cerebrum | 1 | 2012 | 20 | 0.100 |
Why?
|
| Hibernation | 1 | 2011 | 8 | 0.100 |
Why?
|
| Carotid Arteries | 3 | 2007 | 110 | 0.100 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2013 | 133 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2013 | 324 | 0.100 |
Why?
|
| Femoral Artery | 3 | 2007 | 139 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 3 | 2012 | 296 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2018 | 2083 | 0.100 |
Why?
|
| Rats, Long-Evans | 1 | 2011 | 203 | 0.090 |
Why?
|
| Hypertension | 1 | 2020 | 1535 | 0.090 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2009 | 15 | 0.090 |
Why?
|
| Blood Gas Analysis | 3 | 2019 | 41 | 0.090 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2008 | 35 | 0.080 |
Why?
|
| Chorioamnionitis | 2 | 2018 | 40 | 0.080 |
Why?
|
| Aging | 1 | 2013 | 911 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2009 | 954 | 0.070 |
Why?
|
| Infant | 1 | 2013 | 2891 | 0.070 |
Why?
|
| Electron Transport Complex IV | 1 | 2006 | 33 | 0.070 |
Why?
|
| Male | 5 | 2020 | 37321 | 0.070 |
Why?
|
| Mice | 5 | 2019 | 8474 | 0.070 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2018 | 92 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2005 | 128 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 176 | 0.060 |
Why?
|
| Vascular Resistance | 1 | 2005 | 179 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 1174 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 1745 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 2791 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 710 | 0.060 |
Why?
|
| Corpus Striatum | 1 | 2005 | 279 | 0.060 |
Why?
|
| Risk Factors | 1 | 2013 | 5731 | 0.060 |
Why?
|
| Fetal Development | 2 | 2017 | 70 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2005 | 1040 | 0.050 |
Why?
|
| Heart Rate | 2 | 2020 | 568 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2019 | 1034 | 0.050 |
Why?
|
| Action Potentials | 2 | 2014 | 223 | 0.050 |
Why?
|
| Oxygen | 2 | 2018 | 386 | 0.050 |
Why?
|
| Fetal Therapies | 1 | 2021 | 2 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1664 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 137 | 0.050 |
Why?
|
| Societies, Scientific | 1 | 2020 | 18 | 0.050 |
Why?
|
| Etanercept | 1 | 2020 | 12 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2020 | 90 | 0.040 |
Why?
|
| Neuroprotection | 1 | 2020 | 28 | 0.040 |
Why?
|
| Sheep, Domestic | 1 | 2020 | 5 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2018 | 1692 | 0.040 |
Why?
|
| Brain Waves | 1 | 2020 | 30 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2020 | 87 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2020 | 334 | 0.040 |
Why?
|
| Pars Compacta | 1 | 2018 | 1 | 0.040 |
Why?
|
| Enzyme Activation | 2 | 2011 | 791 | 0.040 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2019 | 381 | 0.040 |
Why?
|
| Neuregulin-1 | 1 | 2018 | 20 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2018 | 200 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2018 | 64 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 951 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2012 | 1174 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 2007 | 168 | 0.040 |
Why?
|
| Lactic Acid | 2 | 2007 | 86 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 271 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2007 | 618 | 0.030 |
Why?
|
| Temperature | 1 | 2016 | 341 | 0.030 |
Why?
|
| Molecular Imaging | 1 | 2015 | 45 | 0.030 |
Why?
|
| Goats | 1 | 2014 | 17 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2015 | 143 | 0.030 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2014 | 20 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 29 | 0.030 |
Why?
|
| GABA Agents | 1 | 2014 | 18 | 0.030 |
Why?
|
| Necrosis | 1 | 2014 | 239 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2018 | 753 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2014 | 87 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2077 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2007 | 631 | 0.030 |
Why?
|
| Adolescent Development | 1 | 2013 | 28 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 2007 | 0.030 |
Why?
|
| Lysophosphatidylcholines | 1 | 2013 | 11 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 58 | 0.030 |
Why?
|
| Research Design | 1 | 2016 | 729 | 0.030 |
Why?
|
| Acute-Phase Reaction | 1 | 2011 | 10 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 290 | 0.030 |
Why?
|
| Metabolome | 1 | 2011 | 15 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2012 | 107 | 0.030 |
Why?
|
| Vital Signs | 1 | 2011 | 19 | 0.030 |
Why?
|
| Electromagnetic Fields | 1 | 2011 | 66 | 0.020 |
Why?
|
| Arteries | 1 | 2011 | 108 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2011 | 58 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2011 | 114 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 102 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 2010 | 45 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 659 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 282 | 0.020 |
Why?
|
| Rabbits | 1 | 2010 | 509 | 0.020 |
Why?
|
| Chemokines | 1 | 2009 | 119 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 492 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 507 | 0.020 |
Why?
|
| Diffuse Axonal Injury | 1 | 2007 | 1 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 689 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 1038 | 0.020 |
Why?
|
| Chemoreceptor Cells | 1 | 2007 | 5 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2009 | 432 | 0.020 |
Why?
|
| Fetal Weight | 1 | 2007 | 33 | 0.020 |
Why?
|
| Balloon Occlusion | 1 | 2007 | 22 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 700 | 0.020 |
Why?
|
| Thermogenesis | 1 | 2006 | 5 | 0.020 |
Why?
|
| Hypotension | 1 | 2007 | 74 | 0.020 |
Why?
|
| Edema | 1 | 2006 | 66 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2006 | 78 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 189 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2006 | 131 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 1196 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 567 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2007 | 295 | 0.020 |
Why?
|
| Child | 1 | 2013 | 6405 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 14862 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 8912 | 0.010 |
Why?
|
| Apoptosis | 1 | 2007 | 1641 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 21147 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 21403 | 0.010 |
Why?
|